Terms And Conditions
  1. Home
  2. Terms And Conditions
PYC Therapeutics Limited (ASX: PYC): Signific...
By ACE Investors / 06 Aug 2026
Read More
Clarity Pharmaceuticals Limited (ASX: CU6): M...
By ACE Investors / 06 Aug 2026
Read More
Regis Healthcare Limited (ASX: REG): Long-ter...
By ACE Investors / 04 Aug 2026
Read More
ICU Medical Inc (NASDAQ: ICUI): Results Refle...
By ACE Investors / 31 Jul 2026
Read More
Aft Pharmaceuticals Limited (ASX: AFP) – Bu...
By ACE Investors / 30 Jul 2026
Read More
Amgen Inc. (NASDAQ: AMGN): Reinforced its tra...
By ACE Investors / 30 Jul 2026
Read More
Artrya Limited (ASX: AYA): Significantly stre...
By ACE Investors / 29 Jul 2026
Read More
Polynovo Limited (ASX: PNV): Broadened its ad...
By ACE Investors / 17 Jul 2026
Read More
EBOS Group Limited (ASX: EBO): Undergoing a m...
By ACE Investors / 16 Jul 2026
Read More
Dimerix Limited (ASX: DXB): Addressing a sign...
By ACE Investors / 14 Jul 2026
Read More
Xenon Pharmaceuticals Inc. (NASDAQ: XENE): Su...
By ACE Investors / 14 Jul 2026
Read More
BioMarin Pharmaceutical Inc. (NASDAQ: BMRN): ...
By ACE Investors / 10 Jul 2026
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2025 ACE Investors. All Right Reserved. Design by Ace Investors